Relationship between Serum 25-hydroxy-vitamin D Concentration and Risk of Metabolic Syndrome in Patients with Fatty Liver.
10.11005/jbm.2017.24.4.223
- Author:
Hee Sook LIM
1
;
Tae Hee KIM
;
Hae Hyeog LEE
;
Soon Kyung KIM
;
Bora LEE
;
Yoon Hyung PARK
Author Information
1. Department of Food and Nutrition, Yoensung University, Anyang, Korea.
- Publication Type:Original Article
- Keywords:
Fatty liver;
Metabolic syndrome;
Vitamin D deficiency
- MeSH:
Adult;
Blood Glucose;
Cholesterol;
Demography;
Fatty Liver*;
Humans;
Life Style;
Lipoproteins;
Male;
Obesity;
Risk Factors;
Triglycerides;
Vitamin D;
Vitamin D Deficiency;
Waist Circumference
- From:Journal of Bone Metabolism
2017;24(4):223-228
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: The vitamin D deficiency rate in Koreans is still high and dietary intake is insufficient. The purpose of this study was to provide basic data for the management of metabolic syndrome (MetS) by analyzing the effect of vitamin D levels on the MetS in patients with fatty liver. METHODS: We analyzed the MetS ratio and serum 25-hydroxy-vitamin D (25[OH]D) concentration in 151 adults diagnosed with fatty liver by using obesity index and blood profiles. We collected data on demographic factors, nutrient intake, and lifestyle habits. RESULTS: The mean 25(OH)D concentration of all subjects was 14 ng/mL and the insufficiency and deficiency rates were 40.4% and 29.8%. The proportion of MetS was 38.4% and the mean 25(OH)D level of MetS group was 12.1 ng/mL. Low-density lipoprotein cholesterol, triglyceride, and blood glucose were higher in the MetS group than in the normal group, and the waist circumference of the male was significantly higher than that of the normal group. The results showed that the lower the vitamin D concentration, the higher the risk of MetS (odds ratio, 1.47, 95% confidence interval, 0.98–2.81; P=0.043). CONCLUSIONS: These results suggest that serum 25(OH)D levels may be a risk factor for MetS in patients with fatty liver.
